company background image
BAJAJHCARE logo

Bajaj HealthCare NSEI:BAJAJHCARE Stock Report

Last Price

₹552.90

Market Cap

₹17.9b

7D

-5.5%

1Y

47.3%

Updated

26 Dec, 2024

Data

Company Financials

Bajaj HealthCare Limited

NSEI:BAJAJHCARE Stock Report

Market Cap: ₹17.9b

BAJAJHCARE Stock Overview

A pharmaceutical company, develops, manufactures, markets, and sells active pharmaceutical ingredient, intermediates, and finished dosage forms and nutraceuticals for pharmaceutical, nutraceuticals, and food industries in India and internationally. More details

BAJAJHCARE fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends1/6

My Notes

Capture your thoughts, links and company narrative

Bajaj HealthCare Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Bajaj HealthCare
Historical stock prices
Current Share Price₹552.90
52 Week High₹615.00
52 Week Low₹263.30
Beta0.51
1 Month Change38.64%
3 Month Change44.38%
1 Year Change47.34%
3 Year Change37.45%
5 Year Changen/a
Change since IPO52.34%

Recent News & Updates

Bajaj HealthCare Limited (NSE:BAJAJHCARE) Stock Rockets 46% As Investors Are Less Pessimistic Than Expected

Dec 19
Bajaj HealthCare Limited (NSE:BAJAJHCARE) Stock Rockets 46% As Investors Are Less Pessimistic Than Expected

Estimating The Intrinsic Value Of Bajaj HealthCare Limited (NSE:BAJAJHCARE)

Dec 10
Estimating The Intrinsic Value Of Bajaj HealthCare Limited (NSE:BAJAJHCARE)

Recent updates

Bajaj HealthCare Limited (NSE:BAJAJHCARE) Stock Rockets 46% As Investors Are Less Pessimistic Than Expected

Dec 19
Bajaj HealthCare Limited (NSE:BAJAJHCARE) Stock Rockets 46% As Investors Are Less Pessimistic Than Expected

Estimating The Intrinsic Value Of Bajaj HealthCare Limited (NSE:BAJAJHCARE)

Dec 10
Estimating The Intrinsic Value Of Bajaj HealthCare Limited (NSE:BAJAJHCARE)

Bajaj HealthCare's (NSE:BAJAJHCARE) Dividend Will Be ₹1.00

Sep 12
Bajaj HealthCare's (NSE:BAJAJHCARE) Dividend Will Be ₹1.00

Bajaj HealthCare Limited (NSE:BAJAJHCARE) Stock Catapults 28% Though Its Price And Business Still Lag The Industry

Jul 12
Bajaj HealthCare Limited (NSE:BAJAJHCARE) Stock Catapults 28% Though Its Price And Business Still Lag The Industry

Bajaj HealthCare (NSE:BAJAJHCARE) Has Announced That Its Dividend Will Be Reduced To ₹1.00

Sep 10
Bajaj HealthCare (NSE:BAJAJHCARE) Has Announced That Its Dividend Will Be Reduced To ₹1.00

We Think That There Are More Issues For Bajaj HealthCare (NSE:BAJAJHCARE) Than Just Sluggish Earnings

Nov 19
We Think That There Are More Issues For Bajaj HealthCare (NSE:BAJAJHCARE) Than Just Sluggish Earnings

Bajaj HealthCare Limited (NSE:BAJAJHCARE) Soars 30% But It's A Story Of Risk Vs Reward

Jan 17
Bajaj HealthCare Limited (NSE:BAJAJHCARE) Soars 30% But It's A Story Of Risk Vs Reward

Shareholder Returns

BAJAJHCAREIN PharmaceuticalsIN Market
7D-5.5%0.2%-2.5%
1Y47.3%38.1%17.9%

Return vs Industry: BAJAJHCARE exceeded the Indian Pharmaceuticals industry which returned 38.1% over the past year.

Return vs Market: BAJAJHCARE exceeded the Indian Market which returned 17.9% over the past year.

Price Volatility

Is BAJAJHCARE's price volatile compared to industry and market?
BAJAJHCARE volatility
BAJAJHCARE Average Weekly Movement9.9%
Pharmaceuticals Industry Average Movement6.0%
Market Average Movement6.2%
10% most volatile stocks in IN Market9.1%
10% least volatile stocks in IN Market4.1%

Stable Share Price: BAJAJHCARE's share price has been volatile over the past 3 months compared to the Indian market.

Volatility Over Time: BAJAJHCARE's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Indian stocks.

About the Company

FoundedEmployeesCEOWebsite
19931,049Sajankumar Bajajwww.bajajhealth.com

Bajaj HealthCare Limited, a pharmaceutical company, develops, manufactures, markets, and sells active pharmaceutical ingredient, intermediates, and finished dosage forms and nutraceuticals for pharmaceutical, nutraceuticals, and food industries in India and internationally. The company offers active pharmaceutical ingredient in various therapeutic categories, including anti-diabetic, antibiotic, antiviral, antiplatelet, antifungal, iron-chelating agent, anticonvulsant, growth stimulant, non-steroidal anti-inflammatory drugs, antihypertensive, anthelmintics, anti-asthmatic, antioxidant, urinary tract infection, anti-histamine, weight reducing, venous disease, antimalarial, vitamin c, disinfectant/ antiseptic, stimulant, lipotropic agents, nootropic, vasoprotective/antihemorrhagic, cardiovascular agents, food supplements, anti-anemic, amino acids, antiasthmatic / bronchodilator, nutritional supplement, and minerals. It provides intermediates, such as guanine, 3-methyl xanthine, bromoethyl theophylline, calcium phosphoryl choline chloride, 4-hydrazinobenzoic acid, ticagrelor acetonide, 4,7-dichloroquinolone, 5-[N-ethyl-N-(2-hydroxyethyl)amino]-2-aminopentane, 2-amino -4-hydroxyacetophenone, 8- chloro theophylline, 8 bromo-3-methyl xanthine, 3-methyl-7-(2-butyn-1-yl)-8-bromo xanthine, (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile, 3 – amino – 1 – adamantanol, N – boc -sitagliptin, sitagliptin base, hesperidine, (2,7-dichlori-9H-fluorene), (2-Chloro-1-(2,7- dichlori-9H-fluoren-4-yl)ethanone), (2-(dibutylamino)-1-(2, 7- dichlori-9H-fluoren-4-yl)ethanol), (2-Nitro-4-thiocyanoaniline), 4- (propylthio) benzene -1,2-diamine, methyl [(E)amino(methylsulfanyl)methylidene] carbamate, and (2-phenoxy methane sulphonamide).

Bajaj HealthCare Limited Fundamentals Summary

How do Bajaj HealthCare's earnings and revenue compare to its market cap?
BAJAJHCARE fundamental statistics
Market cap₹17.90b
Earnings (TTM)-₹101.06m
Revenue (TTM)₹5.08b

3.4x

P/S Ratio

-172.9x

P/E Ratio

Is BAJAJHCARE overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BAJAJHCARE income statement (TTM)
Revenue₹5.08b
Cost of Revenue₹2.69b
Gross Profit₹2.39b
Other Expenses₹2.49b
Earnings-₹101.06m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-3.20
Gross Margin46.99%
Net Profit Margin-1.99%
Debt/Equity Ratio46.0%

How did BAJAJHCARE perform over the long term?

See historical performance and comparison

Dividends

0.2%

Current Dividend Yield

-19%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 15:13
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Bajaj HealthCare Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution